Cancer BiologybioRxivPreprint
Metabolic plasticity increases evolvability and drives persistence to PARP inhibitor in ovarian cancer
Adriana Del Pino Herrera, Joon-Hyun Song, Karla Torres‐Arciga…·Meghan C. Ferrall-Fairbanks
Ovarian cancer cells exploit metabolic plasticity to increase their evolvability to persist PARP inhibitor treatment.